S

Septerna

Licenses GPCR discovery platform to pharma

Director, Program and Portfolio Management

Program ManagementConfirmed live in the last 24 hours
Full-timeSouth San Francisco, CA, USA

About the Job

Requirements

  • An advanced degree relevant to drug discovery or development.
  • At least 10–15 years of experience in the biotechnology or pharmaceutical industry, including project management experience in late-stage clinical development.
  • Expertise in project planning, execution, and risk management, with a deep understanding of drug development processes, particularly in endocrinology, inflammation/immunology, and central nervous system (CNS) areas.
  • A demonstrated track record managing small-molecule discovery projects from early-stage development through new drug application (NDA) submissions, clinical trial management, and program strategy development.
  • Experience with commonly used project management tools, including Smartsheet.
  • Ability to execute diverse and novel strategies in a matrix environment and to manage and influence complex issues and varied stakeholders.
  • Demonstrated skill in driving execution and focusing on deliverables.
  • Strong organizational skills, persistent attention to detail, and ability to work independently and collaboratively to manage timelines and priorities.
  • Ability to manage complex situations, adapt to changing business needs, and prioritize multiple tasks.
  • Strong interpersonal and communication skills, with demonstrated ability to collaborate closely with individual project leads, teams, and scientific leadership.
  • Willingness to work on a small team in a fast-paced environment.

Responsibilities

  • Lead program management for one or more development programs from early-stage development through lifecycle management.
  • Partner with the cross-functional Program Team to define program strategy, conduct scenario planning, and translate strategy into executable plans to achieve program objectives.
  • Identify and manage program-level risks, assumptions, and interdependencies; lead mitigation planning and issue resolution.
  • Escalate risks and decision points with clear options and recommendations.
  • Work with teams to prepare presentations for internal and external meetings, including team presentations, abstracts, posters, management reviews, and Board of Directors meetings.
  • Develop and maintain integrated program plans, including milestones, timelines, budgets, and resource assumptions.
  • Monitor progress against plans, identify deviations, and implement mitigation strategies or alternative scenarios.
  • Conduct critical path and dependency analyses to proactively identify risks and bottlenecks.
  • Ensure clear, consistent, and transparent communication of program status, key risks, and upcoming milestones through minutes, action items, and decision tracking.
  • Align diverse stakeholders around priorities, decisions, and execution plans in a matrixed environment.
  • Contribute to the design, implementation, and continuous improvement of program management processes, tools, and templates.
  • Promote best practices in program planning, governance, and execution across the organization.

Desired Qualifications

  • A Ph.D., Pharm.D., or MBA.

About the Company

Septerna

Licenses GPCR discovery platform to pharma

Septerna develops and licenses a platform called Native Complex™ that enables drug discovery on G protein-coupled receptors (GPCRs) outside of cells. The platform reproduces GPCRs with their original structure, function, and dynamics, allowing scientists to design drugs based on GPCR structures and to perform ultra-large-scale screening across the full GPCR target class. This helps unlock GPCR targets that were previously hard to study and could lead to new medicines. The company differentiates itself by offering an industrial-scale, structure-based discovery workflow specifically for GPCRs, paired with a licensing business model for pharmaceutical companies. Its goal is to expand therapeutic options by turning more GPCRs—previously considered undruggable—into viable drug targets and to bring GPCR-targeted medicines to market through licensing and partnerships.

Company size
51-200
Company stage
IPO
Headquarters
South San Francisco, CA
Founded
2022

Recently Posted Jobs

Explore more opportunities at Septerna

See more jobs